UO researcher’s work drives launch of spin-off, Penderia Technologies By Matt Sayre, Contributor, The Register-Guard The Phil and Penny Knight Campus for Accelerating Scientific Impact is not scheduled to open officially until
Oregon Bio recently caught up with Sedia Biosciences Corp.’s two founders, Roger Gale and Ron Mink, Ph.D. to learn more – not only about how its coping with Covid-19 impacts
Last Thursday, Oregon Bio culled together about 100 industry pros for a Diversity Dialogue around equity and inclusion. Participants from a broad range of multi-cultural backgrounds and experiences engaged with
On Thursday, July 30, BIPOC leaders and life science experts will convene for Diversity Dialogue: #BeTheChange. The panelists are respected bio professionals Dr. Emmanuel Akporiaye, founder of Veana Therapeutics; Ndongo
Expansion accommodates significant growth in demand for its new rapid point-of-care HIV tests intended to break the chain of new HIV infections worldwide Sedia Biosciences Corporation, formerly of Portland Oregon,
Oregon Bio recently caught up with Sedia Biosciences Corp.’s founders Roger Gale and Ron Mink, Ph.D. to learn more about the company’s growth and innovation strategies. Recently, Sedia worked with
Not all hand sanitizers are made the same; Efficacy is compromised in many cheaper brands Local Bend based Biotechnology company, Grace Bio Labs, has been producing pharmaceutical grade hand sanitizer
WHO: Mentor early-career life science researchers from groups underrepresented in biotechnology research organizations. Participants include research-active assistant professors, postdoctoral fellows, graduate students and advanced undergraduates from universities and colleges nationwide. WHY:
Phase I Study to Evaluate alpha-TEA in Combination With Trastuzumab (HerceptinTM) in Patients with Advanced HER2 Positive Breast Cancer Portland, OR July 24, 2020 Veana Therapeutics Inc. is pleased to
VANCOUVER, Wash., July 21, 2020 /PRNewswire/ — AbSci, a growth-stage synthetic biology company whose Protein Printing™ technology enables rapid and low-cost biomanufacturing of difficult-to-produce biotherapeutics, today announced that it has entered into an
Many businesses throughout the Pacific Northwest will soon start the process of phased reopening or have already reopened to some extent. This requires employers to take new measures to protect
Oregon Bio has launched an occasional series called Voice of Academia and today, we’re bringing Part 2 (see Part 1 here) of our talk with University of Oregon professor and faculty member
Oregon Bioscience Association Copyright 2023. All Rights Reserved.